PDPN and basal cell carcinoma: Interestingly, Neinaa et al. showed a varying D2-40 expression depending on the underlying tumor entity (basal cell carcinoma, squamous cell carcinoma, basosquamous carcinoma); nevertheless, all examined tumor types differed in their higher podoplanin expression in contrast to physiological control epidermis.